|
1897
|
Marcel Mérieux creates the Institut Mérieux, which developed a large range of vaccines and biological products, including reagents. Alain Mérieux was president of the Institut for 25 years, until 1994.
|
1963
|
Creation of BD Mérieux equally owned by Institut Mérieux and Becton Dickinson.
|
1974
|
Alain Mérieux takes majority control of the company: BD Mérieux becomes bioMérieux.
|
1986
|
API Systems (France) acquisition.
|
1988
|
Vitek acquisition from McDonnel Douglas (U.S.).
|
2001
|
Organon Teknika Diagnostic acquisition from Akzo Nobel (Netherlands).
|
|
2003
|
40th anniversary.
|
2004
|
Listing of bioMérieux on the stock exchange.
|
2006
|
Inauguration of the Christophe Mérieux Center, dedicated to molecular biology and microsystems research (Grenoble, France).
Bacterial Barcodes (U.S.) acquisition - DiversiLab™.
|
2007
|
Biomedics (Spain) acquisition.
BTF (Australia) acquisition.
|
2008
|
Joint venture with Sysmex (Japan).
Joint venture with Shanghai Kehua Bio-engineering (China).
AB BIODISK (Sweden) acquisition.
AviaraDx (U.S.) acquisition - renamed bioTheranostics, Inc.
|
2010
|
Acquisition of Meikang Biotech (China)
Acquisition of Shanghai Zenka Biotechnology (China) |